Safety and Immunogenicity Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen.

Trial Profile

Safety and Immunogenicity Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Nov 2016

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Adverse reactions
  • Acronyms H1N1VAC
  • Most Recent Events

    • 24 Oct 2016 Results of a comparative analysis from NCT01003288 and NCT01866540 studies published in the Vaccine.
    • 14 Jul 2016 Status changed from recruiting to completed.
    • 23 May 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top